REPROSENT
REPROSENT operates the Signal Layer, an EHR-agnostic patient-reported outcomes platform for oncology clinical trials. It sells subscription licensing to biopharma development teams and cancer centers, capturing longitudinal, AI-ready symptom data outside clinic visits for reuse in HEOR, biomarkers, and AI training.
- Company typePrivate
- Founded2020
- HeadquartersSan Francisco, United States
- Headcount1–10
- GTM typeB2B
- OfferingSoftware
What REPROSENT does
REPROSENT is a healthcare technology company founded in 2020 and headquartered in San Francisco that operates a platform branded as the "Signal Layer," a human-signal layer for oncology clinical trials. The platform captures patient-reported symptoms and outcomes in oncology studies through an EHR-agnostic, non-interventional observational overlay, positioning REPROSENT as a data-infrastructure layer that sits between protocol-driven electronic data capture and the real-world symptom experience of cancer patients on therapy. Its core technical claim is the production of structured, AI-ready longitudinal datasets from patient-reported inputs collected outside clinic visits, including dose-aware signals that can be reused across trial programs.
The company's commercial model is subscription or recurring platform licensing, sold into biopharmaceutical development and medical teams as the primary customer segment, with a secondary segment of cooperative groups and cancer centers. Beyond core trial data capture, REPROSENT positions the platform for reuse in health economics and outcomes research (HEOR), digital biomarker development, and AI model training, implying a land-and-expand strategy where a single trial deployment seeds downstream analytic and licensing revenue. No public pricing, contract terms, customer count, or ARR figures are disclosed.
REPROSENT is a small, leanly capitalized company operating with 1-10 employees. Cumulative outside capital disclosed to date is approximately $225,000, consisting of a $125,000 investment from Y Combinator in August 2021 and a $100,000 grant from the Astellas C3 Prize in August 2022. The Astellas award is also the source of the company's only publicly named industry relationship to date. Operations are described as global despite a US-only headquarters footprint, though international commercial activity is not separately verified in the available material.
REPROSENT firmographics
Firmographics- Name
- REPROSENT
- Legal name
- REPROSENT
- Website
- https://reprosent.com
- Company type
- Private
- Founded year
- 2020
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- REPROSENT operates the Signal Layer, an EHR-agnostic patient-reported outcomes platform for oncology clinical trials. It sells subscription licensing to biopharma development teams and cancer centers, capturing longitudinal, AI-ready symptom data outside clinic visits for reuse in HEOR, biomarkers, and AI training.
- Ownership category
- akta.pro rank
REPROSENT industry classification
Industry- Product category
- Oncology Patient-Reported Outcomes Software
- NAICS
- Computer Systems Design and Related Services (54151)
- SIC
- Services-Prepackaged Software (7372)
- akta.pro primary industry
- Real-World Data (RWD) / Real-World Evidence (RWE) & Observational Research Platforms (HLACAOAM)
- akta.pro secondary industries
- Oncology Remote Symptom Monitoring & Care Navigation (HLALAFAD), Healthcare Outcomes & Real-World Evidence (RWE) Analytics (BPAHALAN), Patient Relationship Management (PRM) & CRM for Provider Growth (Marketing/Outreach) (HLACAEAO)
Keywords
Where REPROSENT is headquartered
LocationHeadquarters
- HQ city
- San Francisco
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
REPROSENT business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Personnel, Technology or R&D, Operations, Marketing or Sales
Revenue model
- Platform/SaaS Licensing: REPROSENT provides its human-signal layer as an observational overlay to biopharma companies, cooperative groups, and cancer centers. The platform is deployed alongside existing trials and care programs, suggesting a subscription or licensing model for enterprise clients.
Go-to-market motion1 record
Distribution channels1 record
Marketing channels1 record
REPROSENT product offering
Product offeringCore offering
REPROSENT sells a "Human-Signal Layer for Oncology" called Signal Layer, a SaaS platform that captures patient-reported symptoms via 1-2 minute at-home check-ins and turns them into longitudinal, dose-aware, AI-ready datasets. It deploys as an EHR-agnostic, non-interventional observational overlay on existing oncology trials and care programs, without changing standard AE and safety workflows.
Product overview
REPROSENT offers a single unified product called the Signal Layer — a human-signal layer platform for oncology. The platform has three integrated functional components: (1) Patient-side capture — a 1–2 minute check-in where patients describe their experience in plain language mapped to structured scales; (2) Clinician context — treating teams review concise summaries in-flow, confirm grading where needed, and keep standard adverse event and safety workflows unchanged; and (3) Computable dataset — the platform turns patient data into longitudinal, dose-aware, AI-ready data for reuse across trials, programs, and models. Together, these components capture day-to-day treatment experience and make it usable for dose, safety, and development decisions.
Differentiator
Problem solved
Functional benefit
Products and services
- Signal Layer
Companies that use REPROSENT
Customer profileNamed customers1 record
Segments2 records
Ideal customer profiles2 records
REPROSENT technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability3 records
Feature4 records
REPROSENT partnerships and signals
Strategic signalScale indicators1 record
Recent moves4 records
Expansion highlights5 records
REPROSENT competitors and assessment
Company assessmentEmerging players
- Belong.Life: AI-powered patient engagement platform with a strong oncology community app for symptom tracking and clinician communication. Comparable as an emerging peer in oncology patient-reported symptom capture and engagement.
- Medable: Decentralized clinical trial technology platform providing eCOA, ePRO, and remote data capture for biopharma. Comparable as a venture-backed peer addressing the same hybrid/overlay trial workflows as REPROSENT.
- Yonalink: ePRO and patient-reported outcomes platform purpose-built for clinical trials with remote data capture. Comparable as a younger, eCOA-focused competitor tackling the same sponsor pain point REPROSENT addresses.
Direct peers
- Noona (Varian/Siemens Healthineers): Oncology-specific patient-reported outcomes and symptom management platform used by cancer centers. Closely comparable to REPROSENT's Signal Layer for capturing tolerability data in routine oncology care and trials.
- Signant Health: Specialist in eCOA, ePRO, and patient-centric clinical trial technology with deep oncology experience. Closely comparable to REPROSENT's Signal Layer for capturing patient-reported symptoms in oncology trials.
- Medidata (Dassault Systèmes): Industry-leading eCOA/ePRO and clinical trial technology platform serving biopharma with patient-reported outcome capture in oncology trials. Most directly comparable to REPROSENT as the dominant player in the same product category.
- Clario: Clinical trial technology vendor offering eCOA, ePRO, and decentralized trial solutions to biopharma. Directly comparable in product category and target customer to REPROSENT's oncology-focused PRO overlay.
- Castor: Cloud-based clinical data capture platform used by sponsors and academic centers for decentralized and hybrid trials. Comparable to REPROSENT for capturing structured patient and clinician data in oncology and other therapeutic areas.
Broad incumbents
- Veeva Systems: Life sciences cloud platform spanning clinical, regulatory, and commercial workflows for biopharma. Comparable as a broad incumbent whose clinical and data offerings overlap with REPROSENT's oncology trial positioning.
- IQVIA: Global CRO and life sciences technology provider with broad RWE, eCOA, and oncology evidence offerings. Comparable as a much larger incumbent serving the same biopharma buyers with overlapping patient experience data capabilities.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights6 records
Customer concentration
REPROSENT social profiles
Digital presenceREPROSENT financial estimates
Financial estimateRevenue estimate
Valuation estimate
REPROSENT leadership team
Management profileNumber of profiles
Profiles2 records
REPROSENT funding detail
Funding detailFunding overview
Funding rounds2 records
Investors2 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
REPROSENT M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about REPROSENT
What does REPROSENT do?
REPROSENT sells a "Human-Signal Layer for Oncology" called Signal Layer, a SaaS platform that captures patient-reported symptoms via 1-2 minute at-home check-ins and turns them into longitudinal, dose-aware, AI-ready datasets. It deploys as an EHR-agnostic, non-interventional observational overlay on existing oncology trials and care programs, without changing standard AE and safety workflows.
Is REPROSENT a public or private company?
REPROSENT is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was REPROSENT founded?
REPROSENT was founded in 2020. It employs 1 to 10 people.
Where is REPROSENT based?
REPROSENT is headquartered in San Francisco, United States, in the North America region.
How does REPROSENT make money?
One revenue line is on record: platform/SaaS Licensing.
Who are REPROSENT's main competitors?
Emerging players on record are Belong.Life, Medable and Yonalink. Direct peers are Noona (Varian/Siemens Healthineers), Signant Health, Medidata (Dassault Systèmes), Clario and Castor. Broad incumbents are Veeva Systems and IQVIA.
Does REPROSENT have an API?
No public API is recorded for REPROSENT.
What industry is REPROSENT in?
REPROSENT's product category is Oncology Patient-Reported Outcomes Software. Its primary akta.pro industry code is HLACAOAM, Real-World Data (RWD) / Real-World Evidence (RWE) & Observational Research Platforms, with a secondary code of HLALAFAD, Oncology Remote Symptom Monitoring & Care Navigation. Its NAICS code is 54151 and its SIC code is 7372.